MAHE Digital Repository
Logo

Adjuvant treatment for Stage I seminoma: Why radiotherapy is better than carboplatin

Yathiraj, Prahlad H and Sharan, Krishna and Fernandes, Donald J and Vidyasagar, MS (2016) Adjuvant treatment for Stage I seminoma: Why radiotherapy is better than carboplatin. Journal of Cancer Research and Therapeutics, 12 (4). pp. 1216-1219. ISSN 0973-1482

[img] PDF
RMS - 00002767.pdf - Published Version
Restricted to Registered users only

Download (437kB) | Request a copy

Abstract

Adjuvant treatment options for Stage I seminoma include active surveillance, chemotherapy, and radiotherapy. Active surveillance may not be ideal for the average Indian patient. Of the two accepted adjuvant therapy options, namely single‑dose carboplatin chemotherapy and radiotherapy to the retroperitoneal nodes, though it intuitively appears more appealing, a deeper review reveals the potential drawbacks of chemotherapy. This article highlights the misconceptions regarding carboplatin and provides reasons for an argument why radiotherapy is better when a patient with Stage I seminoma chooses to undergo adjuvant treatment.

Item Type: Article
Uncontrolled Keywords: Adjuvant treatment; carboplatin; radiotherapy; seminoma; Stage I.
Subjects: Medicine > KMC Manipal > Radiotherapy and Oncology
Depositing User: KMC Library
Date Deposited: 27 Jun 2017 04:09
Last Modified: 27 Jun 2017 04:09
URI: http://eprints.manipal.edu/id/eprint/149160

Actions (login required)

View Item View Item